Department of Health retracts claim sunbeds are as dangerous as smoking DHSC corrects statements after regulator intervenes as experts say smoking causes far more cancer cases The Guardian - UK · Mar 21
867-5309: number from 1980s hit song Jenny now routes callers to cancer support Music’s most famous number is being repurposed to offer resources and support for patients and caregivers The Guardian - US · Mar 17
A 'vital' new drug for hot flushes is now available: what does this mean for UK women? Veoza, also known as fezolinetant, was first approved a couple of years ago - and is now available for prescription for those eligible Woman & Home · Mar 13
Draft rare cancers law offers hope to those with incurable brain tumours Abi Feltham was diagnosed with a brain tumour in May 2024 and was told she has 15 years to live. Evening Standard · Feb 27
“These chemicals are not just additives; they may be migrating from the headphones into our body”: Research shows nearly all headphones contain chemicals that are dangerous to human health And they could be absorbed into your skin via sweat MusicRadar · Feb 18
Victims of cancer-linked pregnancy drug to demand public inquiry into ‘silent scandal’ The victims are due to meet with Health Secretary West Streeting on Monday The Independent UK · Feb 9
London firefighters exposed to toxic chemicals face higher risk of cancer, report warns Around one in 25 of the firefighters surveyed by the FBU have reported being diagnosed with cancer Evening Standard · Feb 4
Patients with ‘invisible’ cancer being turned away by doctors Neuroendocrine cancer impacts more than 6,000 people a year in England The Independent UK · Feb 4
Financial toll hangs heavy over cancer patients Australians undergoing cancer treatment are facing out-of-pocket expenses even when accessing the public healthcare system, data reveals. AAP · Feb 3
Cancer drugs among nearly 400 medicines at risk of shortage in UK Exclusive: Drugs to treat stroke and schizophrenia patients could be hit if suppliers no longer see them as commercially viable The Independent UK · Feb 3
King’s support at Sandringham charity parkrun ‘means the world’ Charles cheered on participants on Saturday morning and chatted with local members of Move Against Cancer’s 5K Your Way group. Evening Standard · Feb 1
One in four school leavers have higher cancer risk because they skipped this vaccine A ‘concerning’ number of students are missing out on the crucial HPV vaccines, says health minister The Independent UK · Jan 29
Study finds no stomach cancer link to long-term acid reflux drugs Early research on the links was ‘hampered by several methodological limitations’ says researchers The Independent UK · Jan 21
Scotland first part of UK to approve ‘cutting edge’ treatment for stomach cancer The Scottish Medicines Consortium has approved zolbetuximab – to be used together with chemotherapy – to treat those with advanced stomach cancer. Evening Standard · Jan 19
The Independent UK · Jan 14 United Airlines technician with Stage 4 cancer fired during chemotherapy session, lawsuit says Exclusive: ‘No one should have to choose between their health and their livelihood,’ a lawyer for 737 mechanic Hasan Syed told The Independent
The Independent UK · Dec 20, 2025 Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder A Minnesota jury has awarded $65.5 million to a woman who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing mesothelioma
Woman & Home · Dec 12, 2025 'Early diagnosis quite simply is key' - King Charles's plea as he shares rare health update 'Your life - or the life of someone you love - may depend on it'
The Independent UK · Dec 12, 2025 King Charles III to speak about his cancer treatment, recovery on TV show promoting early screening King Charles III will speak about his cancer diagnosis and recovery during a TV broadcast on Friday as the monarch continues to use his personal story to encourage others to get the early screening that can boost their chances of survival
Benzinga · Dec 9, 2025 BioNTech-Bristol Drug Shows Hope For Breast Cancer Patients With Few Options BioNTech SE (NASDAQ:BNTX) and Bristol Myers Squibb Co. (NYSE:BMY) on Tuesday shared the first interim data from a global randomized Phase 2 trial of pumitamig (BNT327/BMS986545) plus chemotherapy for locally advanced/metastatic triple-negative breast cancer (TNBC) irrespective of PD-L1 expression levels.
Benzinga · Dec 9, 2025 Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial Exicure, Inc. (NASDAQ:XCUR) stock is trading higher on Tuesday. Its session volume was 13.62 million, compared with the average volume of 151.41 thousand, according to data from Benzinga Pro.
Benzinga · Dec 9, 2025 Tiny Biotech Terns Takes Aim At Novartis' Leukemia Blockbuster Terns Pharmaceuticals, Inc. (NASDAQ:TERN) on Monday presented updated and expanded data from the ongoing CARDINAL trial of TERN-701 in previously treated chronic myeloid leukemia (CML) patients at the American Society of Hematology Annual Meeting and Exposition.
Benzinga · Dec 8, 2025 Why Is Arcellx Stock Surging Today? Arcellx Inc. (NASDAQ:ACLX) shared new data on Saturday from its pivotal Phase 2 iMMagine-1 study of anitocabtagene autoleucel (anito-cel) for relapsed or refractory multiple myeloma (RRMM).
Benzinga · Dec 4, 2025 Pliant Cancer Drug Boosts Responses When Paired With Merck's Blockbuster Keytruda In Tough-To-Treat Tumors Pliant Therapeutics, Inc. (NASDAQ:PLRX) is capturing attention with promising trial results for its cancer therapy, despite a sharp stock decline.
Benzinga · Dec 2, 2025 Janux Therapeutics Stock Hits 52-Week Low After Trial Update Janux Therapeutics Inc. (NASDAQ:JANX) stock hit a 52-week low on Tuesday after the company released updated interim data for its JANX007 Phase 1 program for metastatic castration-resistant prostate cancer (mCRPC).
Benzinga · Nov 26, 2025 AstraZeneca Wins FDA Nod For Imfinzi Combination Regimen In Tough-To-Treat Stomach Cancers The U.S. Food and Drug Administration (FDA) on Tuesday approved AstraZeneca Plc's (NASDAQ:AZN) Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) for resectable, early-stage, and locally advanced gastric and gastroesophageal junction (GEJ) cancers.